No Data
No Data
PYC Therapeutics Posts Wider Fiscal H1 Loss, Higher Revenue
PYC Therapeutics Ltd: Half Yearly Report and Accounts
PYC Therapeutics to Raise Nearly AU$146 Million via Entitlement Offer
PYC Therapeutics Initiated at Overweight by Barrenjoey
Experts Reveal 4 ASX Small-cap Shares to Buy Now
PYC Therapeutics' (ASX:PYC) Investors Will Be Pleased With Their Splendid 107% Return Over the Last Five Years
茁壮成长的韭菜 : Awaiting new progress in research and experimental results.
Cracker13 OP : yes they have a few things on the go currently which would be great if they made a breakthrough